Shi Hyun Kang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shi Hyun Kang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Young-Chul Chung
Department of Psychiatry, Jeonbuk National University, Jeonju, South Korea
6 shared publications - Bong Ju Lee
Department of Psychiatry Inje University Haeundae Paik Hospital Busan Republic of Korea
5 shared publications - Jung Jin Kim
Department of Psychiatry, The Catholic University of Korea, Seoul St. Mary’s Hospital, Seoul, Republic of Korea
5 shared publications - Seung-Hwan Lee
Clinical Emotion and Cognition Research Laboratory, Inje University, Goyang, Korea
5 shared publications - Sung-Wan Kim
Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea
5 shared publications - Euitae Kim
Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Korea
4 shared publications
Latest Publications
- Open Access
- 31 August 2022
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 20 (3) , 462-473
Methylome-wide Association Study of Patients with Recent-onset Psychosis
Yan-Hong Piao, Yin Cui, Fatima Zahra Rami, Ling Li, Maryam Karamikheirabad, Shi Hyun Kang, Sung-Wan Kim, Jung Jin Kim, Bong Ju Lee, Young-Chul Chung. Clin Psychopharmacol Neurosci 2022;20:462-73. https://doi.org/10.9758/cpn.2022.20.3.462
- 31 August 2022
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 20 (3) , 462-473
Open AccessMethylome-wide Association Study of Patients with Recent-onset Psychosis
Yan-Hong Piao, Yin Cui, Fatima Zahra Rami, Ling Li, Maryam Karamikheirabad, Shi Hyun Kang, Sung-Wan Kim, Jung Jin Kim, Bong Ju Lee, Young-Chul Chung. Clin Psychopharmacol Neurosci 2022;20:462-73. https://doi.org/10.9758/cpn.2022.20.3.462
- Open Access
- 3 August 2022
- Published by Wiley in Disease Markers
- Vol. 2022, 1-13
DNA Methylation Profiles of the DRD2 and NR3C1 Genes in Patients with Recent-Onset Psychosis
Objectives. Dopamine receptor D2 gene (DRD2) and glucocorticoid receptor gene (NR3C1) are implicated in the development of psychosis. We investigated methylation levels of DRD2 and NR3C1 in peripheral blood of patients with recent-onset (RO) psychosis using bisulfite pyrosequencing as well as its association with childhood trauma and rumination. Methods. In all, 51 individuals with RO psychosis and 47 healthy controls were recruited. DNA methylation levels in the targeted regions of two genes were analyzed and compared. Childhood trauma and rumination were evaluated using the Early Trauma Inventory Self-Report Short Form (ETI-SF) and Brooding Scale (BS), respectively. Correlations between the scores of the ETI-SF and BS and methylation levels were explored. Results. For DRD2, we found no significant differences between groups in terms of methylation level or association with childhood trauma or rumination. For NR3C1, we found a trend level significance for average value of all CpG sites and significant hypermethylation or hypomethylation at specific sites. There was also a significant positive correlation between the methylation level at the CpG8 site of NR3C1 exon 1F and negative symptom subscale score of the PANSS (PANSS-N). Conclusion. Epigenetic alterations of NR3C1 are associated with the pathophysiology of psychosis. Further epigenetic studies will elucidate the molecular mechanisms underpinning the pathophysiology of psychosis.
- 3 August 2022
- Published by Wiley in Disease Markers
- Vol. 2022, 1-13
Open AccessDNA Methylation Profiles of the DRD2 and NR3C1 Genes in Patients with Recent-Onset Psychosis
Objectives. Dopamine receptor D2 gene (DRD2) and glucocorticoid receptor gene (NR3C1) are implicated in the development of psychosis. We investigated methylation levels of DRD2 and NR3C1 in peripheral blood of patients with recent-onset (RO) psychosis using bisulfite pyrosequencing as well as its association with childhood trauma and rumination. Methods. In all, 51 individuals with RO psychosis and 47 healthy controls were recruited. DNA methylation levels in the targeted regions of two genes were analyzed and compared. Childhood trauma and rumination were evaluated using the Early Trauma Inventory Self-Report Short Form (ETI-SF) and Brooding Scale (BS), respectively. Correlations between the scores of the ETI-SF and BS and methylation levels were explored. Results. For DRD2, we found no significant differences between groups in terms of methylation level or association with childhood trauma or rumination. For NR3C1, we found a trend level significance for average value of all CpG sites and significant hypermethylation or hypomethylation at specific sites. There was also a significant positive correlation between the methylation level at the CpG8 site of NR3C1 exon 1F and negative symptom subscale score of the PANSS (PANSS-N). Conclusion. Epigenetic alterations of NR3C1 are associated with the pathophysiology of psychosis. Further epigenetic studies will elucidate the molecular mechanisms underpinning the pathophysiology of psychosis.
- Open Access
- 30 April 2022
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 25 (1) , 10-16
Cognitive Behavioral Therapy for Psychosis
Cognitive behavioral therapy for psychosis (CBTp) is recommended by the National Treatment Guidelines in both the U.K. and the U.S. Consistent reports of moderate effect sizes have led to such interventions being suggested as part of routine clinical practice. However. Access to CBTp is poor due to a variety of factors, including training and resources. Therapeutic developments should be based on the theoretical understanding of cognitive models and psychological process associated with stress-vulnerability model. Cognitive models of psychosis incorporate the role of negative core beliefs, hypervigilance for threat, scanning for confirmatory evidence and safety behavior. The current evidence about CBTp is reviewed regarding various methods such as low-intensity of CBTp, different formats of therapy (e.g., individual or group), and phase of illness (e.g., acute or treatment-resistant) of subjects. This review suggests that that patients with psychosis with various disease phase need to be derived more benefit from appropriate adjunctive CBTp.
- 30 April 2022
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 25 (1) , 10-16
Open AccessCognitive Behavioral Therapy for Psychosis
Cognitive behavioral therapy for psychosis (CBTp) is recommended by the National Treatment Guidelines in both the U.K. and the U.S. Consistent reports of moderate effect sizes have led to such interventions being suggested as part of routine clinical practice. However. Access to CBTp is poor due to a variety of factors, including training and resources. Therapeutic developments should be based on the theoretical understanding of cognitive models and psychological process associated with stress-vulnerability model. Cognitive models of psychosis incorporate the role of negative core beliefs, hypervigilance for threat, scanning for confirmatory evidence and safety behavior. The current evidence about CBTp is reviewed regarding various methods such as low-intensity of CBTp, different formats of therapy (e.g., individual or group), and phase of illness (e.g., acute or treatment-resistant) of subjects. This review suggests that that patients with psychosis with various disease phase need to be derived more benefit from appropriate adjunctive CBTp.
- Open Access
- 25 March 2022
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 19 (3) , 197-206
Development of the Korea-Polyenvironmental Risk Score for Psychosis
Objective Comprehensive understanding of polyenvironmental risk factors for the development of psychosis is important. Based on a review of related evidence, we developed the Korea Polyenvironmental Risk Score (K-PERS) for psychosis. We investigated whether the K-PERS can differentiate patients with schizophrenia spectrum disorders (SSDs) from healthy controls (HCs).Methods We reviewed existing tools for measuring polyenvironmental risk factors for psychosis, including the Maudsley Environmental Risk Score (ERS), polyenviromic risk score (PERS), and Psychosis Polyrisk Score (PPS). Using odds ratios and relative risks for Western studies and the “population proportion” (PP) of risk factors for Korean data, we developed the K-PERS, and compared the scores thereon between patients with SSDs and HCs. In addition, correlation was performed between the K-PERS and Positive and Negative Syndrome Scale (PANSS).Results We first constructed the “K-PERS-I,” comprising five factors based on the PPS, and then the “K-PERS-II” comprising six factors based on the ERS. The instruments accurately predicted participants’ status (case vs. control). In addition, the K-PERS-I and -II scores exhibited significant negative correlations with the negative symptom factor score of the PANSS.Conclusion The K-PERS is the first comprehensive tool developed based on PP data obtained from Korean studies that measures polyenvironmental risk factors for psychosis. Using pilot data, the K-PERS predicted patient status (SSD vs. HC). Further research is warranted to examine the relationship of K-PERS scores with clinical outcomes of psychosis and schizophrenia.
- 25 March 2022
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 19 (3) , 197-206
Open AccessDevelopment of the Korea-Polyenvironmental Risk Score for Psychosis
Objective Comprehensive understanding of polyenvironmental risk factors for the development of psychosis is important. Based on a review of related evidence, we developed the Korea Polyenvironmental Risk Score (K-PERS) for psychosis. We investigated whether the K-PERS can differentiate patients with schizophrenia spectrum disorders (SSDs) from healthy controls (HCs).Methods We reviewed existing tools for measuring polyenvironmental risk factors for psychosis, including the Maudsley Environmental Risk Score (ERS), polyenviromic risk score (PERS), and Psychosis Polyrisk Score (PPS). Using odds ratios and relative risks for Western studies and the “population proportion” (PP) of risk factors for Korean data, we developed the K-PERS, and compared the scores thereon between patients with SSDs and HCs. In addition, correlation was performed between the K-PERS and Positive and Negative Syndrome Scale (PANSS).Results We first constructed the “K-PERS-I,” comprising five factors based on the PPS, and then the “K-PERS-II” comprising six factors based on the ERS. The instruments accurately predicted participants’ status (case vs. control). In addition, the K-PERS-I and -II scores exhibited significant negative correlations with the negative symptom factor score of the PANSS.Conclusion The K-PERS is the first comprehensive tool developed based on PP data obtained from Korean studies that measures polyenvironmental risk factors for psychosis. Using pilot data, the K-PERS predicted patient status (SSD vs. HC). Further research is warranted to examine the relationship of K-PERS scores with clinical outcomes of psychosis and schizophrenia.
- Open Access
- 30 April 2021
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 24 (1) , 36-43
Change of Prescribing Pattern after Clozapine Discontinuation: A Retrospective Chart Review
- 30 April 2021
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 24 (1) , 36-43
Open AccessChange of Prescribing Pattern after Clozapine Discontinuation: A Retrospective Chart Review
- Open Access
- 31 August 2020
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 18 (3) , 386-394
Korean Medication Algorithm for Schizophrenia 2019, Second Revision: Treatment of Psychotic Symptoms
Jung Suk Lee, Je-Yeon Yun, Shi Hyun Kang, Seung Jae Lee, Joon-Ho Choi, Beomwoo Nam, Seung-Hwan Lee, Young-Chul Chung, Chan-Hyung Kim. Clin Psychopharmacol Neurosci 2020;18:386-94. https://doi.org/10.9758/cpn.2020.18.3.386
- 31 August 2020
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 18 (3) , 386-394
Open AccessKorean Medication Algorithm for Schizophrenia 2019, Second Revision: Treatment of Psychotic Symptoms
Jung Suk Lee, Je-Yeon Yun, Shi Hyun Kang, Seung Jae Lee, Joon-Ho Choi, Beomwoo Nam, Seung-Hwan Lee, Young-Chul Chung, Chan-Hyung Kim. Clin Psychopharmacol Neurosci 2020;18:386-94. https://doi.org/10.9758/cpn.2020.18.3.386
- Open Access
- 25 February 2020
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 17 (2) , 163-174
Defining Treatment Response, Remission, Relapse, and Recovery in First-Episode Psychosis: A Survey among Korean Experts
Objective For the proper treatment of first-episode psychosis, assessment of treatment response, remission, relapse, and recovery is important. Therefore, the present study aimed to develop operational definitions of clinical outcomes in first-episode psychosis.Methods A questionnaire was developed by a panel of experts and underwent three revisions. The final survey was presented to 150 psychiatrists who were members of the Korean Society for Schizophrenia Research. Respondents selected factors that they believed were important to consider while defining treatment response, remission, relapse, and recovery using a 6-point Likert scale. Selected factors that constituted each definition were statistically extracted, and operational definitions were developed.Results A total of 91 experts responded to the survey. The extent of reduction in psychopathology, socio-occupational functioning, and duration of each state were the core factors of each definition. Outcomes obtained from discussions and consultations by experts have been summarized and proposed.Conclusion The criteria developed in this survey tended to be somewhat stricter than those used by other studies. The fundamental reason for this is that this survey focused on first-episode psychosis. A better understanding of each definition in first-episode psychosis is necessary to improve effective treatment outcomes.
- 25 February 2020
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 17 (2) , 163-174
Open AccessDefining Treatment Response, Remission, Relapse, and Recovery in First-Episode Psychosis: A Survey among Korean Experts
Objective For the proper treatment of first-episode psychosis, assessment of treatment response, remission, relapse, and recovery is important. Therefore, the present study aimed to develop operational definitions of clinical outcomes in first-episode psychosis.Methods A questionnaire was developed by a panel of experts and underwent three revisions. The final survey was presented to 150 psychiatrists who were members of the Korean Society for Schizophrenia Research. Respondents selected factors that they believed were important to consider while defining treatment response, remission, relapse, and recovery using a 6-point Likert scale. Selected factors that constituted each definition were statistically extracted, and operational definitions were developed.Results A total of 91 experts responded to the survey. The extent of reduction in psychopathology, socio-occupational functioning, and duration of each state were the core factors of each definition. Outcomes obtained from discussions and consultations by experts have been summarized and proposed.Conclusion The criteria developed in this survey tended to be somewhat stricter than those used by other studies. The fundamental reason for this is that this survey focused on first-episode psychosis. A better understanding of each definition in first-episode psychosis is necessary to improve effective treatment outcomes.
- 1 January 2020
- Published by Korean Neuropsychiatric Association in Journal of Korean Neuropsychiatric Association
- Vol. 59 (3) , 228-235
Differences in Symptoms, Functions, and Their Outcomes According to the Degree of Trauma in Patients with Early Psychosis
문서영, et al. J Korean Neuropsychiatr Assoc. 2020 Aug;59(3):228-235. https://doi.org/10.4306/jknpa.2020.59.3.228
- 1 January 2020
- Published by Korean Neuropsychiatric Association in Journal of Korean Neuropsychiatric Association
- Vol. 59 (3) , 228-235
Differences in Symptoms, Functions, and Their Outcomes According to the Degree of Trauma in Patients with Early Psychosis
문서영, et al. J Korean Neuropsychiatr Assoc. 2020 Aug;59(3):228-235. https://doi.org/10.4306/jknpa.2020.59.3.228
- Open Access
- 1 January 2020
- Published by XMLink in Journal of Korean Neuropsychiatric Association
- Vol. 59 (2) , 159-165
Attitude Toward Illness and Treatment in Adherent Schizophrenia Patients: A Qualitative Study
강시현, et al. J Korean Neuropsychiatr Assoc. 2020 May;59(2):159-165. https://doi.org/10.4306/jknpa.2020.59.2.159
- 1 January 2020
- Published by XMLink in Journal of Korean Neuropsychiatric Association
- Vol. 59 (2) , 159-165
Open AccessAttitude Toward Illness and Treatment in Adherent Schizophrenia Patients: A Qualitative Study
강시현, et al. J Korean Neuropsychiatr Assoc. 2020 May;59(2):159-165. https://doi.org/10.4306/jknpa.2020.59.2.159
- Open Access
- 1 January 2019
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 22 (1) , 1-7
Prescribing Pattern of Clozapine and Clinical Factors associated with Discontinuation of Clozapine
- 1 January 2019
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 22 (1) , 1-7
Open AccessPrescribing Pattern of Clozapine and Clinical Factors associated with Discontinuation of Clozapine